Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thrombocytosis in polymyalgia rheumatica]

B Seyfarth1, P Harten, H Löffler

  • 1II. Medizinische Klinik und Poliklinik, Universität Kiel.

Deutsche Medizinische Wochenschrift (1946)
|October 11, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatio-temporal analysis of glass volume processing using ultrashort laser pulses.

Applied optics·2018
Same author

Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.

Journal of neurology·2015
Same author

Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use.

Allergy·2015
Same author

Skin irritability to sodium lauryl sulfate is associated with increased positive patch test reactions.

The British journal of dermatology·2014
Same author

[Cancer of unknown primary. Epidemiology and pathogenesis].

Der Radiologe·2014
Same author

[Structured diagnostics and therapy of the CUP syndrome].

Der Radiologe·2014

Thrombocytosis, or high platelet count, is common in polymyalgia rheumatica and may help diagnose the condition. This elevated platelet count is linked to an increased risk of ischemic complications, especially in elderly patients.

Area of Science:

  • Rheumatology
  • Hematology

Context:

  • Polymyalgia rheumatica (PMR) diagnosis lacks specific markers.
  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are standard diagnostic and monitoring tools for PMR.
  • Thrombocytosis is frequently observed in PMR patients.

Purpose:

  • To investigate the prevalence of thrombocytosis in PMR patients.
  • To determine the correlation between thrombocytosis and ischemic complications in PMR.
  • To assess the diagnostic and prognostic value of thrombocytosis in PMR.

Summary:

  • A retrospective study analyzed 23 PMR patients, finding 74% had thrombocytosis at diagnosis.
  • Platelet counts decreased slower than ESR and CRP, normalizing around day 14.
  • Three patients with ischemic complications had elevated platelet counts.

Related Experiment Videos

Impact:

  • Thrombocytosis can be an additional diagnostic criterion for PMR.
  • Elevated platelet counts in PMR may indicate a higher risk of ischemic events.
  • Consideration of antiplatelet therapy is suggested for high-risk PMR patients.